Pharmamar

PharmaMar, founded in 1986, is a Spanish biopharmaceutical company and a pioneer in the research and development of marine-based oncology treatments. Its focus is on exploring the ocean in search of compounds with antitumor activity, turning the sea into a powerful technological platform for the discovery of new molecules. Consequently, it boasts the world´s largest collection of marine organisms, comprising over 400,000 specimens. 

PharmaMar´s distinctive value lies in its unique approach: researching marine invertebrates as potential sources of medicinal compounds. Through an innovative biotechnological program, the company conducts marine expeditions around the globe to identify and study potential antitumor drugs.

PharmaMar covers the entire drug development process, from the initial research phase through production, logistics, and commercialization, ensuring the medicines reach patients. In Spain, they are leaders in R&D investment relative to their sales and per employee.